Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

Evaluation of single amino acid chelate (SAAC) derivatives for the regioselective radiolabeling of peptides with technetium-99m

Andrea Armstrong and John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1954;
Andrea Armstrong
1McMaster Institute of Applied Radiation Sciences, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Valliant
2McMaster University, Dept of Chemistry and Medical Physics, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1954

Objectives The aim of this work was to investigate the relative radiolabeling kinetics and affinity of a series of SAAC-type ligands for the [99mTc(CO)3]+ core. This information could then be used to select a suitable SAAC unit for radiolabeling peptide-based targeting vectors in high yield under mild conditions.

Methods A series of protected lysine derivatives were synthesized via reductive amination reactions and complexes of [Re(CO)3]+ were prepared as characterization standards. The SAAC ligands were labeled with 99mTc under a variety of conditions; competitive labeling experiments were also conducted in the presence of histidine and Gly-His-Gly.

Results Three SAAC derivatives were capable of forming complexes with 99mTc at ambient temperature. Residual ligand was removed in minutes using a resin-capture approach. Competition experiments indicated that the bis-thiazolyl and bis-pyridyl derivatives label preferentially over internal histidine residues, while only the bis-thiazolyl compound labeled significantly in the presence of free histidine. Incorporation of the 2-pyridyl-SAAC enabled the rapid, high yield labeling of a uPAR-targeting cyclic peptide without interfering with the essential disulfide bridge.

Conclusions The lead agent is the bis-thiazole SAAC derivative which demonstrated superior affinity for [99mTc(CO)3]+, though the bis-(2-pyridine) analogue displayed comparable efficiency in several instances and is generated from more readily available starting materials. A further benefit of this work was that the resin capture purification method has potential for the rapid generation of 99mTc-labeled peptides in high effective specific activity.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of single amino acid chelate (SAAC) derivatives for the regioselective radiolabeling of peptides with technetium-99m
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of single amino acid chelate (SAAC) derivatives for the regioselective radiolabeling of peptides with technetium-99m
Andrea Armstrong, John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1954;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of single amino acid chelate (SAAC) derivatives for the regioselective radiolabeling of peptides with technetium-99m
Andrea Armstrong, John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1954;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Radiolabeling optimization of a cysteine-dextran lymph node seeking molecule using 99mTc-tricarbonyl core
  • 111In-DTPA-exendin-4 SPECT/CT scans localize hardly detectable insulinomas
  • Radioimmunoscintigraphy of experimental artery thrombi in rabbits with 99mTc labeled monoclonal anti-GPIII a antibody
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

New Radiopharmaceuticals-Novel Probe Development Posters

  • Iodine-131 D-amino acid peptide, a novel bi-functional chelating agent for improving therapeutic application of Rituximab
  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
  • 18F-Peptide probe for PET imaging of VEGF expression
Show more New Radiopharmaceuticals-Novel Probe Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire